ProMIS Neurosciences Inc. (PMN) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ProMIS Neurosciences Inc. (PMN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.88

-0.05 (-5.39%)

At close: Jan 15, 2025, 9:48 AM

undefined% (undefined)

Bid	0.9
Market Cap	28.74M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.04
PE Ratio (ttm)	21.98
Forward PE	n/a
Analyst	Buy

Ask	0.92
Volume	17,565
Avg. Volume (20D)	71,322
Open	0.91
Previous Close	0.93
Day's Range	0.88 - 0.91
52-Week Range	0.87 - 2.72
Beta	undefined

About PMN

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded protei...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jan 10, 2007

Employees 6

Stock Exchange NASDAQ

Ticker Symbol PMN

Website https://www.promisneurosciences.com

Analyst Forecast

According to 1 analyst ratings, the average rating for PMN stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

2 months ago · Source

+5.83%

ProMIS Neurosciences shares are trading higher aft... Unlock content with Pro Subscription

5 months ago · Source

-17.47%

ProMIS Neurosciences shares are trading lower. The company presented preclinical data at the 2024 Alzheimer's Association International Conference.

News

1 year ago · proactiveinvestors.com

ProMIS Neurosciences submits IND application for Alzheimer's treatment

ProMIS Neurosciences (TSX:PMN) told investors it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for PMN310 for the treatment of Alzheimer's di...